These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9430402)

  • 1. Modulatory role of lipoprotein oxidation on platelet-vessel wall interactions.
    Bruckdorfer KR
    Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):493-7. PubMed ID: 9430402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From low-density lipoprotein to platelet activation.
    Akkerman JW
    Int J Biochem Cell Biol; 2008; 40(11):2374-8. PubMed ID: 18468940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis.
    Siegel-Axel D; Daub K; Seizer P; Lindemann S; Gawaz M
    Cardiovasc Res; 2008 Apr; 78(1):8-17. PubMed ID: 18218686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR
    Zeibig S; Büttcher M; Goebel S; Pauli J; Hunger A; Ungerer M; Gawaz M; Münch G
    Cell Physiol Biochem; 2019; 52(4):681-695. PubMed ID: 30921507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidants, lipoprotein oxidation, and arterial function.
    Bruckdorfer KR
    Lipids; 1996 Mar; 31 Suppl():S83-5. PubMed ID: 8729099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein.
    Siess W
    Pathophysiol Haemost Thromb; 2006; 35(3-4):292-304. PubMed ID: 16877878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy.
    Aviram M; Hussein O; Rosenblat M; Schlezinger S; Hayek T; Keidar S
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):39-45. PubMed ID: 9456275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of plasma lipoproteins on platelet responsiveness and on platelet and vascular prostanoid synthesis.
    Bruckdorfer KR
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(4):247-54. PubMed ID: 2561310
    [No Abstract]   [Full Text] [Related]  

  • 9. Modified low-density lipoproteins and high-density lipoproteins. From investigation tools to real in vivo players.
    Koller E; Volf I; Gurvitz A; Koller F
    Pathophysiol Haemost Thromb; 2006; 35(3-4):322-45. PubMed ID: 16877881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of membrane glycoproteins in platelet interaction with oxidized low-density lipoprotein.
    Takahashi Y; Fuda H; Yanai H; Akita H; Shuping H; Chiba H; Matsuno K
    Semin Thromb Hemost; 1998; 24(3):251-3. PubMed ID: 9701456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of platelet function by class B scavenger receptors in hyperlipidemia.
    Zimman A; Podrez EA
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2350-6. PubMed ID: 21071700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein as a modulator of platelet and coagulation responses.
    van der Stoep M; Korporaal SJ; Van Eck M
    Cardiovasc Res; 2014 Aug; 103(3):362-71. PubMed ID: 24891399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipoproteins in platelet activation.
    Zhao B
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):270-3. PubMed ID: 8735837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine, coagulation, platelet function, and thrombosis.
    Coppola A; Davi G; De Stefano V; Mancini FP; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2000; 26(3):243-54. PubMed ID: 11011842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase-dependent production of reactive oxygen species in platelets. Effects on oxidation of low density lipoproteins.
    Kälvegren H; Bylin H; Leanderson P; Richter A; Grenegård M; Bengtsson T
    Thromb Haemost; 2005 Aug; 94(2):327-35. PubMed ID: 16113822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein oxidation and atherosclerosis.
    Young IS; McEneny J
    Biochem Soc Trans; 2001 May; 29(Pt 2):358-62. PubMed ID: 11356183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypochlorite modified LDL are a stronger agonist for platelets than copper oxidized LDL.
    Volf I; Roth A; Cooper J; Moeslinger T; Koller E
    FEBS Lett; 2000 Oct; 483(2-3):155-9. PubMed ID: 11042272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation in atherogenesis associated with low-grade inflammation.
    Antoniades C; Bakogiannis C; Tousoulis D; Demosthenous M; Marinou K; Stefanadis C
    Inflamm Allergy Drug Targets; 2010 Dec; 9(5):334-45. PubMed ID: 20632958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.
    Siess W; Zangl KJ; Essler M; Bauer M; Brandl R; Corrinth C; Bittman R; Tigyi G; Aepfelbacher M
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6931-6. PubMed ID: 10359816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.